Comprehensive medication guide to Trifluoperazine including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$20 copay for generic trifluoperazine on most commercial insurance plans (Tier 1–2 generic); Medicare Part D typically $0–$15 per fill. Prior authorization is uncommon but possible on some managed care plans.
Estimated Cash Pricing
$25–$55 retail for a 30-day supply of generic trifluoperazine; as low as $9.06 with a GoodRx coupon or $5.64 with SingleCare for the most common version.
Medfinder Findability Score
52/100
Summarize with AI
On this page
Trifluoperazine is a first-generation (typical) antipsychotic medication in the phenothiazine chemical class. It was FDA-approved in 1959 and was originally marketed under the brand name Stelazine, which is no longer available in the United States. All trifluoperazine in the US is now sold as a generic by manufacturers including Mylan (Viatris), Sandoz, and Upsher-Smith.
Trifluoperazine is primarily used to treat schizophrenia — a serious mental illness affecting how a person thinks, feels, and behaves. It is also FDA-approved for the short-term management of generalized anxiety disorder (GAD) at lower doses for a maximum of 12 weeks. The drug is available as oral tablets in four strengths: 1 mg, 2 mg, 5 mg, and 10 mg.
As a high-potency typical antipsychotic, trifluoperazine is effective at controlling hallucinations, delusions, and disorganized thinking, but carries a significant risk of extrapyramidal side effects (EPS) including tardive dyskinesia — which is the main reason newer atypical antipsychotics have become preferred as first-line treatments.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Trifluoperazine works primarily by blocking dopamine D1 and D2 receptors in the brain — specifically in the mesolimbic and mesocortical pathways. In schizophrenia, the dopamine hypothesis holds that these pathways are overactive, leading to positive symptoms such as hallucinations and delusions. By occupying dopamine receptors and preventing dopamine from binding, trifluoperazine reduces this hyperactivity and controls psychotic symptoms.
In addition to dopamine blockade, trifluoperazine has central antiadrenergic effects (which can cause orthostatic hypotension and dizziness), mild antihistaminic properties (contributing to sedation), and minimal anticholinergic activity. Unlike atypical antipsychotics, it does not block serotonin receptors — which is why it lacks protection against extrapyramidal side effects in the nigrostriatal pathway, making movement disorders a more prominent concern.
The antipsychotic effect of trifluoperazine typically begins to develop within the first week of treatment, with optimal therapeutic response usually occurring within 2–3 weeks. The drug has a long action, allowing twice-daily or sometimes once-daily dosing for maintenance in stable patients.
1 mg — tablet
Starting or low-maintenance dose; less commonly stocked than 2 mg and 5 mg
2 mg — tablet
Common starting and maintenance dose; most widely stocked by pharmacies
5 mg — tablet
Mid-range dose; widely stocked; used for maintenance therapy
10 mg — tablet
Higher dose for patients requiring more aggressive symptom control; less commonly stocked
Trifluoperazine has a findability score of 52/100 — meaning patients frequently encounter availability challenges at their local pharmacies, even though the drug is not currently in an official FDA-declared shortage. The ASHP documented a formal trifluoperazine shortage beginning in October 2018, which resolved at the manufacturer level over the following years. However, pharmacy-level stocking of this medication remains inconsistent in 2026.
Three manufacturers — Mylan (Viatris), Sandoz, and Upsher-Smith — produce trifluoperazine tablets for the US market. All four strengths (1 mg, 2 mg, 5 mg, 10 mg) are available, but many chain pharmacies no longer keep standing inventory due to the drug's declining prescription volume. The 2 mg and 5 mg strengths are most commonly stocked; the 1 mg and 10 mg strengths are harder to find.
To find trifluoperazine at a pharmacy near you, use medfinder — a service that contacts pharmacies in your area and texts you which ones can fill your prescription. Independent pharmacies and hospital outpatient pharmacies tend to have better stock than chain pharmacies for this medication.
Trifluoperazine is not a controlled substance and is not scheduled by the DEA. This means any licensed prescriber — from psychiatrists to primary care physicians to nurse practitioners — can prescribe it without the additional regulatory requirements that apply to controlled substances. There are no DEA registration requirements specific to trifluoperazine, no limits on refills, and no requirement for in-person prescribing.
Psychiatrists — most common prescribers; manage schizophrenia and complex psychiatric conditions
Primary care physicians (PCPs) — can prescribe for established patients and short-term anxiety indication
Psychiatric nurse practitioners (PMHNPs) — can prescribe in most states, often independently
Physician assistants (PAs) — can prescribe under supervising physician
Neurologists — may prescribe for select cases
Telehealth prescribing is possible for trifluoperazine since it is not a controlled substance. Established patients who are clinically stable can often receive refills via telehealth appointments. New patients beginning antipsychotic therapy for schizophrenia typically benefit from an in-person psychiatric evaluation, but telehealth follow-up care is widely available on platforms like Talkiatry and through community mental health centers.
No. Trifluoperazine is not a controlled substance. The DEA has not scheduled it, and there are no federal restrictions on the number of refills, no requirement for in-person prescribing, and prescriptions can be sent electronically to any licensed pharmacy without restriction. Patients can transfer their trifluoperazine prescription between pharmacies at any time.
This is an important distinction from some other psychiatric medications such as benzodiazepines (Schedule IV) or stimulants (Schedule II), which have strict DEA restrictions. Because trifluoperazine is unscheduled, it can also be prescribed via telehealth without the limitations that apply to controlled substances. Patients can request 90-day supplies, mail-order delivery, and early refills as permitted by their insurance plan.
Drowsiness and sedation
Dizziness (particularly upon standing — orthostatic hypotension)
Blurred vision
Dry mouth
Constipation
Photosensitivity (increased sunburn risk)
Tardive dyskinesia (TD): involuntary movements, potentially irreversible; annual incidence up to 4%
Extrapyramidal symptoms (EPS): drug-induced Parkinsonism, akathisia, acute dystonia
Neuroleptic malignant syndrome (NMS): rare but life-threatening; fever, rigidity, confusion
Blood disorders: agranulocytosis, neutropenia, leukopenia
Liver damage (hepatotoxicity): jaundice, elevated liver enzymes
Hyperprolactinemia: elevated prolactin causing breast discharge, sexual dysfunction, bone effects
Eye deposits (cornea/lens): with long-term high-dose use
Know what you need? Skip the search.
Haloperidol (Haldol)
Most similar first-generation antipsychotic; high-potency typical; available in tablet, liquid, and injection forms; similar EPS risk profile to trifluoperazine; widely stocked
Perphenazine (Trilafon generic)
Mid-potency phenothiazine in same class as trifluoperazine; CATIE trial data shows comparable efficacy to some SGAs; favorable metabolic profile; low cost generic
Risperidone (Risperdal generic)
Atypical antipsychotic; lower EPS risk than trifluoperazine; also treats bipolar disorder and autism-related irritability; widely available low-cost generic
Quetiapine (Seroquel generic)
Atypical antipsychotic; low EPS risk; also used for bipolar disorder and adjunct depression; significant sedation and metabolic effects; widely stocked
Prefer Trifluoperazine? We can find it.
CNS depressants (opioids, benzodiazepines, muscle relaxants)
majorAdditive CNS depression; risk of profound sedation, respiratory depression, coma, and death
Amisulpride
majorContraindicated combination — significantly increased risk of neuroleptic malignant syndrome (NMS)
Metrizamide (contrast dye)
majorIncreased seizure risk; trifluoperazine must be discontinued 24 hours before myelogram
Alcohol
majorAdditive CNS depression; avoid all alcohol use during trifluoperazine therapy
Levodopa/carbidopa
moderateTrifluoperazine antagonizes dopamine, reducing levodopa efficacy in Parkinson's disease
Givosiran
moderateCYP1A2 inhibitor that increases trifluoperazine blood levels; dose reduction may be required
Antihypertensive medications
moderateAdditive blood pressure lowering; risk of excessive hypotension and falls
Trifluoperazine is an older but still clinically relevant antipsychotic medication, particularly for patients who have been stable on it for years or who cannot tolerate newer alternatives. Its low cost — often under $10/month with discount coupons — makes it an important option in cost-constrained settings. However, its significant risk of extrapyramidal side effects, particularly tardive dyskinesia, means careful monitoring and regular AIMS assessments are essential for anyone on long-term therapy.
The main practical challenge with trifluoperazine in 2026 is not cost but availability. Pharmacy-level stocking is inconsistent due to its declining prescription volume. Patients should plan ahead for refills, consider mail-order pharmacy for 90-day supplies, and use services that locate pharmacy stock before gaps arise.
If you're struggling to find trifluoperazine at your pharmacy, medfinder can help. Simply provide your medication, dose, and location — medfinder contacts pharmacies near you and texts you the results. It's the fastest way to locate trifluoperazine in stock without calling every pharmacy yourself.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards